MED12 and leiomyoma: Principal component analysis using the 3′RNA sequencing data revealed that the 49 (44 leiomyomas + 5 myometrium) samples and 11 technical replicates grouped according to the predetermined mutation status of MED12, HMGA2, and FH (Figure 1).